Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function

Gastroenterology Research and Practice
Luca PastorelliM Vecchi

Abstract

Inflammatory and immune mediated disorders are risk factors for arterial and venous thromboembolism. Inflammatory bowel diseases (IBD) confer an even greater risk of thromboembolic events than other inflammatory conditions. It has been shown that IBD patients display defective intestinal barrier functions. Thus, pathogen-associated molecular patterns (PAMPs) coming from the intestinal bacterial burden might reach systemic circulation and activate innate immunity receptors on endothelial cells and platelets, promoting a procoagulative state. Aim of the study was to test this hypothesis, correlating the presence of circulating PAMPs with the activation of innate immune system and the activation of the coagulatory cascade in IBD patients. Specifically, we studied lipopolysaccharide (LPS), Toll-like receptor (TLR) 2, TLR4, and markers of activated coagulation (i.e., D-Dimer and prothrombin fragment F1+2) in the serum and plasma of IBD patients. We found that LPS levels are increased in IBD and correlate with TLR4 concentrations; although a mild correlation between LPS and CRP levels was detected, clinical disease activity does not appear to influence circulating LPS. Instead, serum LPS correlates with both D-Dimer and F1+2 measurem...Continue Reading

References

Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Nov 1, 1972·The American Journal of Digestive Diseases·R G ShorterR J Spencer
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K I IwamiY Yoshikai
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·C T Esmon
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emmanuel LeBouderMario O Labéta
Mar 8, 2005·Immunology and Cell Biology·Fabrice CognasseOlivier Garraud
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Aug 8, 2008·The American Journal of Gastroenterology·Geoffrey C Nguyen, Justina Sam
Apr 16, 2009·Clinical Microbiology Reviews·Trine H Mogensen
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Guoying ZhangZhenyu Li
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne-Catherine RabyMario O Labéta
Mar 3, 2010·Annual Review of Immunology·Arthur KaserRichard S Blumberg
Dec 3, 2010·Journal of Crohn's & Colitis·A DignassUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Mar 1, 2008·Journal of Crohn's & Colitis·E F StangeUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Jan 5, 2011·Thrombosis Research·Jari Petäjä
Feb 9, 2011·Gut·C W LeesJ Satsangi
Feb 15, 2011·Inflammatory Bowel Diseases·Alexandra I Thompson, Charlie W Lees
Mar 25, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·G Thomas Brown, Thomas M McIntyre
Apr 5, 2013·Alimentary Pharmacology & Therapeutics·H YuharaT Mine
May 3, 2013·BMC Medicine·Johan Frostegård
Sep 3, 2013·Nature Reviews. Immunology·Kathryn J MooreEdward A Fisher
Dec 12, 2013·Archives of Medical Research·Luis Chávez-SánchezFrancisco Blanco-Favela
Jan 31, 2014·Journal of Clinical Microbiology·Emanuela GallieraMassimiliano M Corsi Romanelli
Jun 3, 2014·BMC Medical Genomics·William R SwindellJohann E Gudjonsson
Oct 1, 2014·International Journal of Dermatology·Katerina KondelkovaCtirad Andrys

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.